Brand-Name Drugmakers: A Prescription For Access

Brand-Name Drugmakers: A Prescription For Access

More than 300 lobbyists work Washington for the brand-name prescription drug industry. The trade group Pharmaceutical Research and Manufacturers of America alone spent $6.15 million on lobbying in the second quarter, from April 1 to June 30, this year.

Roll over the dots below to see spending totals for each firm. Click to download the firm's lobby disclosure form, with names of lobbyists.


Not included in this graphic: $35 million spent by PhRMA's member corporations, and unknown sums spent on grass-roots lobbying and advertising.


Related NPR Stories



Please keep your community civil. All comments must follow the Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

NPR thanks our sponsors

Become an NPR sponsor

Support comes from